Related Experiment Videos
Characterization of a leukemia-derived transforming growth factor
1Department of Microbiology, University of Texas Health Science Center, Dallas 75235.
Leukemia
|November 1, 1987
Summary
Researchers discovered a novel leukemia-derived transforming growth factor from acute lymphoblastic leukemia cells. This growth factor is biochemically distinct from known mitogens and does not appear to directly impact leukemia cell growth.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Acute lymphoblastic leukemia (ALL) is a significant hematologic malignancy.
- Understanding novel growth factors in leukemia is crucial for targeted therapies.
Purpose of the Study:
- To identify and characterize novel transforming growth factor (TGF) activities in leukemia cell cultures.
- To determine the biochemical properties and biological relevance of a newly identified TGF.
Main Methods:
- Serum-free medium from SMS-SB human pre-B ALL cell line cultures was analyzed.
- Biochemical characterization involved heparin affinity chromatography, gel filtration, and ion-exchange chromatography.
- Mitogenic activity was assessed using agar colony and proliferation assays on various cell types.
Main Results:
- A novel TGF activity, termed leukemia-derived transforming growth factor (Leuk-TGF), was identified.
- Leuk-TGF exhibited heterogeneity, yielding three distinct peaks on heparin affinity chromatography.
- This activity was resistant to heat, acid, and sulfhydryl reduction, and showed similar behavior across multiple chromatographic methods.
- Leuk-TGF was not mitogenic for normal or leukemic lymphocytes or myeloid progenitors.
Conclusions:
- A novel TGF distinct from established mitogens was isolated from leukemia cells.
- Leuk-TGF's unique biochemical properties suggest it may represent a new class of growth factors.
- The lack of mitogenic activity on hematopoietic progenitors suggests Leuk-TGF may not have a direct autocrine or paracrine role in leukemia proliferation.